| Literature DB >> 27165490 |
Mario Brondani1, Steve Chang2, Leeann Donnelly3.
Abstract
BACKGROUND: As a public health initiative, provided-initiated HIV screening test in dental settings has long been available in the U.S.; it was only in 2011 that such setting was used in Canada. The objective of this paper was to assess patients' response to, and attitudes towards, an opt-out rapid HIV screening test in a dental setting in Vancouver, Canada.Entities:
Keywords: Dental setting; Diagnosis; HIV; Patient care; Patient’s perspective; Quantitate research; Screening; Survey
Mesh:
Year: 2016 PMID: 27165490 PMCID: PMC4862228 DOI: 10.1186/s13104-016-2067-6
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Fig. 1Finger prick Rapid HIV test used in this study (bioLytical INSTI™)
Demographic characteristics of 519 patients completing the survey about an opt-out HIV rapid testing in a dental clinic
| Participants | Number (%) |
|---|---|
| Male | 370 (71) |
| Female | 149 (29) |
| Accepting the HIV screening | 61 (12) |
| Declining the HIV screening | 458 (88) |
| Age distribution (years) | |
| 19–24 | 78 (15) |
| 25–44 | 384 (74) |
| ≥45 | 57 (11) |
| Risk factors (not mutually exclusive) | |
| MSMa | 92 (18) |
| Unprotected sexual activities in the past 3 monthsb | 189 (36.5) |
| Intravenous drug useb | 12 (2.5) |
| Unprotected sexual activities in the past 3 months + intravenous drug use | 70 (13) |
| No identifiable risk factor | 156 (30) |
aMen who have sex with men
bYes/no
Distribution of agreement levels of 519 respondents according to gender as per the statement ‘diagnosing HIV is part of a dentists’ job
| Gender | SA (n = 268 %) | A (n = 176 %) | D (n = 62 %) | SD (n = 13 %) |
|
|---|---|---|---|---|---|
| HIV screening is part of dental care | |||||
| Male (n = 270) | 176 (65.6) | 124 (70.4) | 41 (66.2) | 11 (84.6) | <0.01 |
| Female (n = 128) | 92 (34.4) | 52 (29.6) | 21 (33.8) | 2 (15.4) | |
SA strongly agree, A agree, D disagree, SD strongly disagree
a P value corresponds to the test of liner trend for categorical data using the Cochran-Mantel–Haenszel Chi square test
Estimated unadjusted odds ratios (OR) using multivariate logistic regression analysis HIV screening test
| HIV screening | HIV screening | ORb (95 % CI) |
| |
|---|---|---|---|---|
| Gender |
|
| ||
| Male | 280 (77) | 93 (60) | 0.89 (0.69–1.08) | 0.215 |
| Female | 84 (23) | 62 (40) | 2.36 (2.09–3.01) | 0.047 |
| Being tested previouslya |
|
| ||
| Less than 3 months | 100 (44.8) | 25 (26.3) | 2.42 (2.11–2.87) | 0.001 |
| More than 3 months | 123 (55.2) | 70 (73.4) | 0.93 (0.73–1.01) | 0.109 |
| Identifiable risk for HIV infectionc |
|
| ||
| Yes | 250 (68.7) | 97 (62.6) | 1.88 (1.19–2.11) | 0.060 |
| No | 114 (31.3) | 58 (37.4) | 0.94 (0.77–0.99) | 0.271 |
Data from this table refers to the 519 respondents who completed the questionnaire
aThe data refers only to those who reported being screened for HIV at any time in their lives. 201 were never screened for HIV and are not shown
bThe reference group was ‘HIV screening—declining’. The coefficient estimated indicated likelihood of accepting the HIV screening
cIncluded all 519 respondents including those who reported having had unprotected intercourse and/or using of intravenous drugs for the past 3 months